세포 처리 장치 시장(2024-2031년)

Cell Processing Instrument Market Size, Share & Trends Analysis Report by Type (Cell Counters, Cell Imaging Systems, Flow Cytometers, Cell Separator Systems, Automated Cell Processing Systems, and Other Instruments), by Application (Cell Isolation/Separation, Cell Imaging & Counting, Cell Viability & Proliferation, and Other Applications), and by End-User (Pharmaceutical & Biotechnology Companies, CROs & CMOs, Academic & Research Institutes, and Others) Forecast Period (2024-2031)

Cell processing instrument market is anticipated to grow at a CAGR of 6.4% during the forecast period (2024-2031). Cell processing instrument is a specialized tool used to manipulate and prepare cells for various purposes, including cell-based therapies, regenerative medicine, and vaccine development. Its importance lies in utilizing healthy cells to fight diseases or repair damaged tissues.

Market Dynamics

Increasing Government Support

Governments around the world are increasingly recognizing the potential of cell-based therapies and are providing financial support for R&D activities in this area. This support is helping to accelerate the development of new cell therapies and is also creating a more favorable market environment for cell processing instrument manufacturers. For instance, in February 2024, the NIH announced a new $200 million initiative to support research on gene editing for cell-based therapies. This funding will go towards developing safer and more effective gene therapies, which will rely heavily on advanced cell processing instruments.

Technological Advancements

Technological advancements are leading to the development of new and more sophisticated cell processing instruments. These instruments are making it possible to process cells more efficiently and effectively, which is essential for the development of cell-based therapies. For instance, in April 2023 Digitize Designs launched the RM-300 Automated Mobile 3D Scanning Inspection Workstation, a portable and affordable solution for manufacturing. The RM-300 integrates with the assembly line, making metrology and part inspection more accessible and eliminating common errors.

Market Segmentation

Our in-depth analysis of the global cell processing instrument market includes the following segments by type, application, and end-user:

• Based on type, the market is segmented into cell counters, cell imaging systems, flow cytometers, cell separator systems, automated cell processing systems, and other instruments including centrifuges, and CO2 incubators.
• Based on application, the market is segmented into cell isolation/separation, cell imaging & counting, cell viability & proliferation, and other applications including cell harvesting.
• Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, CROs & CMOs, and academic & research institutes.

Cell Separator Systems is Projected to Emerge as the Largest Segment

The increasing demand for cell-based therapies and technological advancements in cell separator systems is a key contributor to the high share of this market segment. The increasing prevalence of chronic diseases and the role cell separators play in these therapies underscore the importance of these technologies.

However, the cell processing systems sub-segment is expected to grow over the coming years. Technological advancements in robotics, automation, and integration will enhance these systems' functionality and user-friendliness. Microfluidic cell processing systems, an emerging technology, offer advantages such as miniaturization, cost-effectiveness, precise control, and rapid prototyping and experimentation. They are attractive for small labs and point-of-care applications, with high growth potential driven by scalability needs.

Regional Outlook

The global cell processing instrument market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

North America Holds Major Market Share

Among all the regions, North America holds a significant share of the global market. The presence of robust healthcare infrastructure, favorable regulatory environments, and high investments in R&D related to biotechnology are major contributors to the regional market share. Major manufacturers like Thermo Fisher Scientific and Danaher Corporation are headquartered in North America, allowing for faster innovation and market adaptation. The concept of personalized medicine is also gaining traction, further stimulating the cell processing instrument market across the region.

The major companies serving the global cell processing instrument market include Agilent Technologies Inc., Danaher Corp., Thermo Scientific Inc., Merck KGaA, and Beckman Coulter, Inc. among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market. For instance, in May 2023, BD announced the commercial launch of BD FACSDiscover S8 Cell Sorter, a first-of-its-kind that uses a high-speed cell imaging system. Thus, this instrument features two technologies, which would enable researchers to understand cells more precisely and effectively.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Market Trends
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Danaher Corp.
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. Merck KGaA
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Thermo Fisher Scientific Inc.
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Cell Processing Instruments Market by Type
  • 4.1.1. Cell Counters
  • 4.1.2. Cell Imaging Systems
  • 4.1.3. Flow Cytometers
  • 4.1.4. Cell Separator Systems
  • 4.1.5. Automated Cell Processing Systems
  • 4.1.6. Other Instruments (Centrifuges, and CO2 Incubators)
• 4.2. Global Cell Processing Instruments Market by Application
  • 4.2.1. Cell Isolation/Separation
  • 4.2.2. Cell Imaging & Counting
  • 4.2.3. Cell Viability & Proliferation
  • 4.2.4. Other Applications (Cell Harvesting)
• 4.3. Global Cell Processing Instruments Market by End-User
  • 4.3.1. Pharmaceutical & Biotechnology Companies
  • 4.3.2. CROs & CMOs
  • 4.3.3. Academic & Research Institutes

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World
  • 5.4.1. Latin America
  • 5.4.2. Middle East & Africa

6. Company Profiles

• 6.1. Advanced Instruments Inc.
• 6.2. Agilent Technologies Inc.
• 6.3. Avantor, Inc.
• 6.4. BD Biosciences
• 6.5. Beckman Coulter, Inc.
• 6.6. Bio-Rad Laboratories, Inc.
• 6.7. Corning Inc.
• 6.8. Bio-Techne Corp.
• 6.9. Miltenyi Biotec
• 6.10. Revvity Inc.
• 6.11. Sartorius AG
• 6.12. Scale Ready USA
• 6.13. STEMCELL Technologies, Inc.
• 6.14. Maxcyte Inc.